Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
J.P. Morgan Now Expects Two ECB Rate Hikes Amid Inflation Pressures 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Asian Markets Mixed as Oil Volatility and Inflation Fears Weigh on Sentiment 
The pandemic is still disrupting young people’s careers 
Judge Dismisses Sam Altman Sexual Abuse Lawsuit, But Sister Can Refile 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Tesla FSD EU Approval Delayed to April 10 as RDW Completes Final Review 
U.S. Markets Post Fourth Straight Weekly Loss Amid Middle East Escalation 
OpenAI's Desktop Superapp: Unifying ChatGPT, Codex, and Browser Tools for Enterprise AI 
EA's $15B Debt Offering Draws $25B in Investor Demand Amid Credit Market Turmoil 
Iran Threatens Gulf Infrastructure as U.S.-Israel War Enters Critical 48-Hour Window 
U.S. Stock Futures Slide as Iran Conflict and Inflation Fears Rattle Wall Street 
Iran War Fears Send Oil Prices Surging as U.S. Weighs Ground Troop Deployment 
CJ Wellcare Corp. will begin selling its 10 health supplement products on Amazon this week in a bid to expand its business in the US.
The move comes amid a growing number of health-conscious American consumers, especially since the pandemic.
The US health functional food market is expected to grow up to US$15 billion by 2026, according to CJ Wellcare.
The CJ Group affiliate said it further plans to expand to the Southeast Asian market through Shopee, one of the largest e-commerce sites in the region.
